LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Feb. 28, 2025 |
|
| Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] | ||||||||||||
| Net loss | $ 1,850,493 | $ 1,981,293 | $ 15,941,328 | $ 765,710 | $ 216,269 | $ 96,923 | $ 230,970 | $ 19,773,114 | $ 544,162 | |||
| Net cash outflows from operations | 3,995,647 | $ 744,755 | ||||||||||
| Accumulated deficit | 22,550,347 | 2,777,233 | 22,550,347 | $ 2,777,233 | ||||||||
| Working capital deficit | 11,457,377 | 11,457,377 | ||||||||||
| Cash | $ 1,948,271 | 3,633 | $ 1,948,271 | 3,633 | ||||||||
| Business combination proceeds | $ 265,827 | |||||||||||
| Business combination additional amount | $ 3,000,000 | |||||||||||
| Aspire Biopharma Inc [Member] | ||||||||||||
| Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] | ||||||||||||
| Net loss | 1,309,872 | $ 359,070 | ||||||||||
| Net cash outflows from operations | 265,186 | (11,136) | ||||||||||
| Accumulated deficit | 2,777,233 | 2,777,233 | 1,467,361 | |||||||||
| Cash | $ 3,633 | $ 3,633 | $ 11,174 | |||||||||
| X | ||||||||||
- Definition Business acquisition cost transaction expenses additional. No definition available.
|
| X | ||||||||||
- Definition Working capital deficit. No definition available.
|
| X | ||||||||||
- Definition Fair value of receivable purchased without credit deterioration, acquired in business combination. Excludes purchased financial asset with credit deterioration. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|